The Cost of Raising Individuals with Fragile X or Chromosome 15 Imprinting Disorders in Australia

[1]  M. Field,et al.  DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome , 2020, International journal of molecular sciences.

[2]  Meghan T. Miller,et al.  Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model , 2020, Child psychiatry and human development.

[3]  A. Franzese,et al.  Caring and living with Prader-Willi syndrome in Italy: integrating children, adults and parents’ experiences through a multicentre narrative medicine research , 2020, BMJ Open.

[4]  R. Viney,et al.  Societal cost of childhood intellectual disability in Australia. , 2020, Journal of intellectual disability research : JIDR.

[5]  Rujuta B. Wilson,et al.  Behavioral characterization of dup15q syndrome: Toward meaningful endpoints for clinical trials , 2019, American journal of medical genetics. Part A.

[6]  S. A. Vera,et al.  Intellectual functioning and behavioural features associated with mosaicism in fragile X syndrome , 2019, Journal of Neurodevelopmental Disorders.

[7]  H. Moll,et al.  An overview of health issues and development in a large clinical cohort of children with Angelman syndrome , 2019, American journal of medical genetics. Part A.

[8]  D. J. Driscoll,et al.  Early Diagnosis in Prader–Willi Syndrome Reduces Obesity and Associated Co-Morbidities , 2019, Genes.

[9]  L. Bird,et al.  Healthcare burden among individuals with Angelman syndrome: Findings from the Angelman Syndrome Natural History Study , 2019, Molecular genetics & genomic medicine.

[10]  J. Schweitzer,et al.  Cognitive training for children and adolescents with fragile X syndrome: a randomized controlled trial of Cogmed , 2019, Journal of neurodevelopmental disorders.

[11]  D. Amor,et al.  Exploring autism symptoms in an Australian cohort of patients with Prader-Willi and Angelman syndromes , 2018, Journal of Neurodevelopmental Disorders.

[12]  C. Dissanayake,et al.  Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X , 2018, Scientific Reports.

[13]  C. Dissanayake,et al.  Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X , 2018, Scientific Reports.

[14]  M. Raspa,et al.  Public Health Literature Review of Fragile X Syndrome , 2017, Pediatrics.

[15]  M. Butler,et al.  Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey , 2016, Genetics in Medicine.

[16]  M. Butler,et al.  The High Direct Medical Costs of Prader-Willi Syndrome , 2016, The Journal of pediatrics.

[17]  G. Iskrov,et al.  Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe , 2016, The European Journal of Health Economics.

[18]  T. Nazareth,et al.  Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective , 2016, Current medical research and opinion.

[19]  L. Zwaigenbaum,et al.  Autism spectrum disorder in Prader–Willi syndrome: A systematic review , 2015, American journal of medical genetics. Part A.

[20]  Chris Oliver,et al.  Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis. , 2015, The lancet. Psychiatry.

[21]  Stormy J. Chamberlain,et al.  Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes. , 2015, Pediatric clinics of North America.

[22]  J. Loeber,et al.  Current status of newborn screening worldwide: 2015. , 2015, Seminars in perinatology.

[23]  J. Brazier,et al.  Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome , 2014, Quality of Life Research.

[24]  Dalyir I. Pretto,et al.  Clinical and molecular implications of mosaicism in FMR1 full mutations , 2014, Front. Genet..

[25]  D. Loesch,et al.  Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots. , 2014, Clinical chemistry.

[26]  S. Spence,et al.  A survey of seizures and current treatments in 15q duplication syndrome , 2014, Epilepsia.

[27]  John O. Willis,et al.  Wechsler Intelligence Scale for Children–Fourth Edition , 2014 .

[28]  John O. Willis,et al.  Wechsler Adult Intelligence Scale–Fourth Edition , 2014 .

[29]  D. Wechsler,et al.  Wechsler Adult Intelligence Scale - fourth edition , 2012 .

[30]  D H Geschwind,et al.  Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts , 2012, Molecular Psychiatry.

[31]  Allan L. Reiss,et al.  Psychometric Study of the Aberrant Behavior Checklist in Fragile X Syndrome and Implications for Targeted Treatment , 2012, Journal of autism and developmental disorders.

[32]  C. Doran,et al.  How much does intellectual disability really cost? First estimates for Australia , 2012, Journal of intellectual & developmental disability.

[33]  D. Bailey,et al.  Employment impact and financial burden for families of children with fragile X syndrome: findings from the National Fragile X Survey. , 2010, Journal of intellectual disability research : JIDR.

[34]  E. Scholte,et al.  Maternal parenting stress in families with a child with Angelman syndrome or Prader–Willi syndrome , 2010, Journal of intellectual & developmental disability.

[35]  Клинические дисциплины.  Autism Diagnostic Observation Schedule , 2010 .

[36]  M. Tauber,et al.  Endocrine Disorders in Children with Prader-Willi Syndrome – Data from 142 Children of the French Database , 2010, Hormone Research in Paediatrics.

[37]  A. Salvatoni,et al.  The Italian National Survey for Prader–Willi syndrome: An epidemiologic study , 2008, American journal of medical genetics. Part A.

[38]  A. Thomson,et al.  A long-term population-based clinical and morbidity profile of Angelman syndrome in Western Australia: 1953–2003 , 2006, Disability and rehabilitation.

[39]  S. Bradley-Johnson.  Mullen Scales of Early Learning , 1997 .

[40]  E. Thiele,et al.  Angelman syndrome in adulthood , 1996, American journal of medical genetics. Part A.

[41]  V. Wright,et al.  Endocrine disorders , 1991, Current opinion in rheumatology.

[42]  M. Aman,et al.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. , 1985, American journal of mental deficiency.

[43]  S. Freeman.  Wechsler Preschool and Primary Scale of Intelligence , 2021, Encyclopedia of Autism Spectrum Disorders.

[44]  E. Dykens,et al.  Cognitive and adaptive advantages of growth hormone treatment in children with Prader‐Willi syndrome , 2017, Journal of child psychology and psychiatry, and allied disciplines.

[45]  A. Thomsona,et al.  A long-term population-based clinical and morbidity profile of Angelman syndrome in Western Australia : 1953 – 2003 , 2006 .

[46]  Martin Knapp,et al.  Costing psychiatric interventions. , 1992 .

[47]  P. Feros.  Pharmaceutical benefits scheme. , 1986, The Medical journal of Australia.